- Susan Wood RD - Matthew's Friends Clinics, UK
- Neil Bindeman PhD - Exec. Dir. Primary Care and Community Neurology Society
Sue Wood discusses why there is so much scientific interest into the possibility of managing brain tumours with KDT.
Topics covered include:
- Overview of current clinical evidence
- Barriers to accessing KDT on NHS
- The patient experience